The Clorox Company (CLX) Income Statement

The reported quarterly series shows revenue oscillating between roughly $1.4B and $2.0B, which suggests that year-over-year growth rates are dominated by timing and comparison effects rather than a clear underlying trend. The sharp rebound in the most recent quarter appears to follow an unusually soft first quarter, so investors should treat the 33.3% figure as a base effect rather than evidence of sustained acceleration. Durability cannot be confirmed from this data alone, and volume versus pricing contribution is not disclosed in the supplied figures.

The gross margin band suggests a premium brand position that partially absorbs commodity volatility, but the recent compression toward 40% indicates that resin and chemical cost inflation may not yet be fully passed through to shelf prices. The data does not isolate pricing from mix, so the relative contribution of each cannot be determined. Investors should monitor whether margins recover toward the mid-40s as input costs stabilize.

Because SG&A is relatively stable at roughly $400M to $530M per quarter, the sharp operating income swings appear driven by non-recurring or classification items rather than changes in core overhead efficiency. This pattern makes it difficult to assess true operating leverage from the reported line items alone. Analysts should normalize for these items before drawing conclusions about cost scalability.